Brief: GIC's Long Position In CStone Pharma Falls To 5.99% - HKEx Filing
15/09/2022 10:03
Sept 15 (Reuters) - Hong Kong stock exchange:
* GIC PRIVATE LTD'S LONG POSITION IN CSTONE PHARMACEUTICALS
2616.HK FALLS TO 5.99% ON SEPT 9 FROM 6.01% - HKEX FILING
Source text https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20220915E00104&sa2=ns&sid=233581&sd=15/09/2021&ed=15/09/2022&sa1=cl&scsd=15/09/2021&sced=15/09/2022&sc=02616&src=Main&lang=EN&tk=ds
Further company coverage: 2616.HK
(Reporting by Hong Kong newsroom)
((meg.shen@thomsonreuters.com; 852-39525805;))
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026